LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) granted equity awards covering 87,000 shares of company stock to four newly hired employees, using inducement incentives as the clinical-stage biotechnology company advances its lead rare-disease therapy through late-stage development. The awards were approved on June 11 by the compensation committee of Savara’s board of directors and were granted under the company’s 2021 Inducement Equity Incentive Pla…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.